Acute Bacterial Skin and Skin Structure Infection, Bacterial Infections
Conditions
Keywords
Critical Pathways, Health Facilities, Clinical Protocols, Patient Satisfaction, Absenteeism, Anti-Bacterial Agents, Quality of Life, Economics, Medical, Health Resources, Health resource utilization, Acute bacterial skin and skin structure infection (ABSSSI)
Brief summary
The purpose of this study is to assess the effect of a new critical pathway (use of guideline-based patient identification criteria and for those who meet these criteria, use of dalbavancin) compared to usual care for the treatment of ABSSI (Acute Bacterial Skin and Skin Structure Infections)
Interventions
DRUGDalbavancin
Dalbavancin administered as a single IV dose of 1500 mg over 30 minutes.
DRUGUsual Care
Usual care as prescribed by the physician as standard of care in clinical practice for the treatment of ABSSSI.
Sponsors
Allergan
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Admitted patients who meets the clinical definition for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) * Known or suspected gram-positive infection.
Exclusion criteria
* Known or suspected gram-negative infections, anaerobic infections, or fungemia * Known or suspected infections that are severe, life threatening or are not included in the ABSSSI Food and Drug Administration (FDA) guidance * Injection drug users with a fever * Severe neurological disorder leading to immobility or confined to a wheelchair * Bilateral Lower extremity involvement of the suspected infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Infection-related Total Admitted Hospital Days | 44 Days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Total Admitted Hospital Days | 44 Days | — |
| Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time | 44 Days | — |
| Number of Participants With Infection-related Hospitalizations | 44 Days | — |
| Number of Participants With Infection-related Hospitalizations That Resulted in Admission to Intensive Care Unit | 44 Days | — |
| Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital | Follow-up: 30 Days | — |
| Number of Participants With Infection-related Emergency Department (ED) Visits | 44 Days | — |
| Number of Participants With Infection-related Outpatient Healthcare Visits | 44 Days | — |
| Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | 44 Days | — |
| Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy | 44 Days | — |
| Change From Baseline in Response to Treatment at End of Treatment Visit | Baseline, Day 14 | Response to treatment (healthcare provider assessment) comparing response at the Day 14 visit. Response to treatment will be defined through an assessment of erythema (measurement of lesion characteristics) and the absence of fever |
| Number of Participants With Serious Adverse Events (SAEs) | 44 Days | — |
| Patient Satisfaction With Care: Overall Health | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Wait in Emergency Room | 14 Days | Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible. |
| Patient Satisfaction With Care: Hospitalization | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Satisfaction With Hospital Stay | 14 Days | Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible. |
| Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Satisfaction With Receiving IV Antibiotic Therapy | 14 Days | Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible. |
| Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Satisfied With the Number of IV Infusions Received Per Day | 14 Days | Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible. |
| Patient Satisfaction With Care: Satisfaction With the Average Time to Administer Each IV | 14 Days | Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible. |
| Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Satisfaction With Care: Find Value in a Physician | 14 Days | Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported). |
| Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Day 10-14 | — |
| Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire | Day 14 | The SF-12 yields a physical and a mental health component summary score (referred to as physical component summary score \[PCS\] and mental component summary score \[MCS\]). The PCS and MCS follow a t-score distribution, i.e. mean of 50 and standard deviation of 10 in the general US population, meaning all scores above or below 50 are above and below the average, respectively, in the US general population. |
| Healthcare Costs | 44 Days | Cost of hospital inpatient stays, ED visits, healthcare visits, procedures, and biological tests |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Usual Care Participants who receive Usual Care as prescribed by the physician as standard of care in clinical practice for the treatment of ABSSSI. | 48 |
| New Critical Pathway The New Critical Pathway under study is defined as (1) use of guideline-based patient identification criteria, and, for those who meet these criteria, (2) use of dalbavancin, administered as a single intravenous (IV) dose of 1500 mg over 30 minutes for the treatment of ABSSSI. | 42 |
| Total | 90 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 4 | 9 |
| Overall Study | No recording of dalbavancin | 0 | 1 |
| Overall Study | Withdrawal by Subject | 2 | 1 |
Baseline characteristics
| Characteristic | Usual Care | New Critical Pathway | Total |
|---|---|---|---|
| Age, Customized 20-29 years | 6 Participants | 5 Participants | 11 Participants |
| Age, Customized <20 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Customized 30-39 years | 6 Participants | 8 Participants | 14 Participants |
| Age, Customized 40-49 years | 4 Participants | 8 Participants | 12 Participants |
| Age, Customized 50-59 years | 7 Participants | 5 Participants | 12 Participants |
| Age, Customized 60-69 years | 10 Participants | 5 Participants | 15 Participants |
| Age, Customized 70-79 years | 4 Participants | 3 Participants | 7 Participants |
| Age, Customized 80-89 years | 7 Participants | 7 Participants | 14 Participants |
| Age, Customized 90-98 years | 4 Participants | 1 Participants | 5 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 7 Participants | 8 Participants | 15 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 38 Participants | 26 Participants | 64 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 3 Participants | 8 Participants | 11 Participants |
| Race/Ethnicity, Customized American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race/Ethnicity, Customized Asian | 1 Participants | 1 Participants | 2 Participants |
| Race/Ethnicity, Customized Black or African American | 1 Participants | 7 Participants | 8 Participants |
| Race/Ethnicity, Customized Native Hawaiian or Other Pacific Islander | 0 Participants | 1 Participants | 1 Participants |
| Race/Ethnicity, Customized Other | 0 Participants | 0 Participants | 0 Participants |
| Race/Ethnicity, Customized Patient chose not to answer | 10 Participants | 5 Participants | 15 Participants |
| Race/Ethnicity, Customized White or Caucasian | 36 Participants | 28 Participants | 64 Participants |
| Sex: Female, Male Female | 24 Participants | 20 Participants | 44 Participants |
| Sex: Female, Male Male | 24 Participants | 22 Participants | 46 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 48 | 0 / 42 |
| other Total, other adverse events | 0 / 48 | 3 / 42 |
| serious Total, serious adverse events | 1 / 48 | 3 / 42 |
Outcome results
Primary
Number of Infection-related Total Admitted Hospital Days
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Number of Infection-related Total Admitted Hospital Days | 4.8 Days | Standard Deviation 2.55 |
| New Critical Pathway | Number of Infection-related Total Admitted Hospital Days | 3.2 Days | Standard Deviation 2.48 |
p-value: 0.00395% CI: [0.6, 2.6]t-test, 2 sided
Secondary
Change From Baseline in Response to Treatment at End of Treatment Visit
Response to treatment (healthcare provider assessment) comparing response at the Day 14 visit. Response to treatment will be defined through an assessment of erythema (measurement of lesion characteristics) and the absence of fever
Time frame: Baseline, Day 14
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Change From Baseline in Response to Treatment at End of Treatment Visit | Complete response | 24 Participants |
| Usual Care | Change From Baseline in Response to Treatment at End of Treatment Visit | Partial response | 0 Participants |
| Usual Care | Change From Baseline in Response to Treatment at End of Treatment Visit | Failure | 12 Participants |
| Usual Care | Change From Baseline in Response to Treatment at End of Treatment Visit | Unknown | 12 Participants |
| New Critical Pathway | Change From Baseline in Response to Treatment at End of Treatment Visit | Unknown | 9 Participants |
| New Critical Pathway | Change From Baseline in Response to Treatment at End of Treatment Visit | Complete response | 24 Participants |
| New Critical Pathway | Change From Baseline in Response to Treatment at End of Treatment Visit | Failure | 9 Participants |
| New Critical Pathway | Change From Baseline in Response to Treatment at End of Treatment Visit | Partial response | 0 Participants |
Secondary
Healthcare Costs
Cost of hospital inpatient stays, ED visits, healthcare visits, procedures, and biological tests
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Healthcare Costs | 13772.9 USD | Standard Deviation 7166.95 |
| New Critical Pathway | Healthcare Costs | 9421.6 USD | Standard Deviation 7122.57 |
Secondary
Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital
Time frame: Follow-up: 30 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital | None | 47 Participants |
| Usual Care | Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital | 1 Occurrence | 1 Participants |
| New Critical Pathway | Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital | None | 39 Participants |
| New Critical Pathway | Number of Participants With All Cause Hospitalizations in the 30 Days Post Discharge From the Hospital | 1 Occurrence | 3 Participants |
Secondary
Number of Participants With Infection-related Emergency Department (ED) Visits
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Emergency Department (ED) Visits | None | 46 Participants |
| Usual Care | Number of Participants With Infection-related Emergency Department (ED) Visits | 1 Occurrence | 2 Participants |
| New Critical Pathway | Number of Participants With Infection-related Emergency Department (ED) Visits | None | 40 Participants |
| New Critical Pathway | Number of Participants With Infection-related Emergency Department (ED) Visits | 1 Occurrence | 2 Participants |
Secondary
Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy | None | 45 Participants |
| Usual Care | Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy | 1 Occurrence | 3 Participants |
| New Critical Pathway | Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy | None | 41 Participants |
| New Critical Pathway | Number of Participants With Infection-related Healthcare Visits Due to PICC Line or Central Line Used to Administer Antibiotic Therapy | 1 Occurrence | 1 Participants |
Secondary
Number of Participants With Infection-related Hospitalizations
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Hospitalizations | 1 Occurrence | 48 Participants |
| Usual Care | Number of Participants With Infection-related Hospitalizations | 2 Occurrences | 0 Participants |
| New Critical Pathway | Number of Participants With Infection-related Hospitalizations | 1 Occurrence | 39 Participants |
| New Critical Pathway | Number of Participants With Infection-related Hospitalizations | 2 Occurrences | 3 Participants |
Secondary
Number of Participants With Infection-related Hospitalizations That Resulted in Admission to Intensive Care Unit
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Hospitalizations That Resulted in Admission to Intensive Care Unit | Admission to ICU | 0 Participants |
| New Critical Pathway | Number of Participants With Infection-related Hospitalizations That Resulted in Admission to Intensive Care Unit | Admission to ICU | 0 Participants |
Secondary
Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time | No Surgeries | 48 Participants |
| Usual Care | Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time | Expected Surgeries | 0 Participants |
| New Critical Pathway | Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time | No Surgeries | 41 Participants |
| New Critical Pathway | Number of Participants With Infection-related Major Surgical Interventions That Required Operating Room Time | Expected Surgeries | 1 Participants |
Secondary
Number of Participants With Infection-related Outpatient Healthcare Visits
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Number of Participants With Infection-related Outpatient Healthcare Visits | None | 26 Participants |
| Usual Care | Number of Participants With Infection-related Outpatient Healthcare Visits | Any | 22 Participants |
| New Critical Pathway | Number of Participants With Infection-related Outpatient Healthcare Visits | None | 20 Participants |
| New Critical Pathway | Number of Participants With Infection-related Outpatient Healthcare Visits | Any | 22 Participants |
Secondary
Number of Participants With Serious Adverse Events (SAEs)
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Usual Care | Number of Participants With Serious Adverse Events (SAEs) | 1 Participants |
| New Critical Pathway | Number of Participants With Serious Adverse Events (SAEs) | 3 Participants |
Secondary
Number of Total Admitted Hospital Days
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Number of Total Admitted Hospital Days | 4.9 Days | Standard Deviation 2.62 |
| New Critical Pathway | Number of Total Admitted Hospital Days | 3.2 Days | Standard Deviation 2.48 |
p-value: 0.00395% CI: [0.6, 2.8]t-test, 2 sided
Secondary
Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire
The SF-12 yields a physical and a mental health component summary score (referred to as physical component summary score \[PCS\] and mental component summary score \[MCS\]). The PCS and MCS follow a t-score distribution, i.e. mean of 50 and standard deviation of 10 in the general US population, meaning all scores above or below 50 are above and below the average, respectively, in the US general population.
Time frame: Day 14
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 42 and 34 patients completed all survey questions in the usual care group and new critical pathway group, respectively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Usual Care | Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire | Mental Health Component Score | 43.9 score on a scale | Standard Deviation 10.28 |
| Usual Care | Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire | Physical Health Component Score | 40.5 score on a scale | Standard Deviation 11.37 |
| New Critical Pathway | Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire | Mental Health Component Score | 50.8 score on a scale | Standard Deviation 10.85 |
| New Critical Pathway | Patient Health-related Quality of Life (HRQoL) Assessed by the Short Form 12 (SF-12) 12-Item Patient Questionnaire | Physical Health Component Score | 46.3 score on a scale | Standard Deviation 11.15 |
Secondary
Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 42 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | A little of the time | 13 Participants |
| Usual Care | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | Most of the time | 1 Participants |
| Usual Care | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | Some of the time | 3 Participants |
| Usual Care | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | All of the time | 2 Participants |
| Usual Care | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | None of the time | 23 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | All of the time | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | None of the time | 26 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | A little of the time | 4 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | Some of the time | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Concerned About Receiving Your IV Therapy | Most of the time | 1 Participants |
Secondary
Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this question in the usual care group \& new critical pathway group, respectively. Patients may have checked multiple responses.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in the way of work/school | 11 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in way of performing daily normal activities | 11 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in the way of providing care to others | 5 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy was expensive | 2 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required me to make appointments | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Administered at healthcare setting w/limited hours | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required traveling to and from appointments | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required to wait to be seen by provider | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy took too long to administer | 4 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Administered too frequently | 4 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required having a PICC or central line inserted | 7 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Caused an IV site infection | 1 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy made me feel worse | 10 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not adequately monitored by healthcare providers | 3 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not administered by skilled healthcare providers | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy made me feel concerned | 7 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required a nurse/healthcare worker coming to home | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required administration to self/caregiver at home | 0 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Other | 1 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not dissatisfied w/receiving IV antibiotic therapy | 19 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required administration to self/caregiver at home | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in the way of work/school | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required having a PICC or central line inserted | 2 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in way of performing daily normal activities | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy made me feel concerned | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Got in the way of providing care to others | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Caused an IV site infection | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy was expensive | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not dissatisfied w/receiving IV antibiotic therapy | 22 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required me to make appointments | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy made me feel worse | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Administered at healthcare setting w/limited hours | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required a nurse/healthcare worker coming to home | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required traveling to and from appointments | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not adequately monitored by healthcare providers | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Required to wait to be seen by provider | 5 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Other | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | IV antibiotic therapy took too long to administer | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Not administered by skilled healthcare providers | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Dissatisfaction With Receiving IV | Administered too frequently | 1 Participants |
Secondary
Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this question in the usual care group \& new critical pathway group, respectively. Patients may have checked multiple responses.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to work/school | 14 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to daily normal activities | 15 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to providing care to others | 8 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | IV antibiotic therapy was affordable | 6 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered at appointments that I could schedule | 2 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered quickly once arrived at appt | 2 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered at setting that had convenient hours | 3 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Ensured regular monitoring by healthcare providers | 22 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered by skilled healthcare providers | 24 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | IV antibiotic therapy made me feel better | 19 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed to receive care for skin infection at home | 7 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Convenient to administer by self/caregiver at home | 4 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Other | 3 Participants |
| Usual Care | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Not satisfied with receiving IV antibiotic therapy | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed to receive care for skin infection at home | 9 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to work/school | 15 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Ensured regular monitoring by healthcare providers | 10 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to daily normal activities | 20 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Other | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Allowed me to return to providing care to others | 11 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered by skilled healthcare providers | 18 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | IV antibiotic therapy was affordable | 4 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Convenient to administer by self/caregiver at home | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered at appointments that I could schedule | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | IV antibiotic therapy made me feel better | 16 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered quickly once arrived at appt | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Not satisfied with receiving IV antibiotic therapy | 2 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors Contributing to Satisfaction With Receiving IV | Administered at setting that had convenient hours | 7 Participants |
Secondary
Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all questions in the usual care group \& new critical pathway group; 42 \& 34 patients answered this question in the usual care group \& new critical pathway group, respectively. Patients may have checked multiple responses.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay interfered with work/school | 13 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Stay got in way of daily normal activities | 17 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Stay got in the way of providing care to others | 10 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay was expensive | 7 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Did not provide adequate monitoring by providers | 4 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Did not provide well trained healthcare providers | 3 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay made me feel worse | 4 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay made me feel concerned | 11 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay was uncomfortable | 12 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay disrupted my sleep | 24 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Other | 5 Participants |
| Usual Care | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | I was not dissatisfied with my hospital stay | 12 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Other | 6 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay interfered with work/school | 6 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay made me feel worse | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Stay got in way of daily normal activities | 8 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay disrupted my sleep | 10 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Stay got in the way of providing care to others | 5 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay made me feel concerned | 7 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay was expensive | 4 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | I was not dissatisfied with my hospital stay | 12 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Did not provide adequate monitoring by providers | 4 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Hospital stay was uncomfortable | 7 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Factors for Dissatisfaction With Your Hospital Stay | Did not provide well trained healthcare providers | 1 Participants |
Secondary
Patient Satisfaction With Care: Find Value in a Physician
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 34 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Find Value in a Physician | Definitely not | 1 Participants |
| Usual Care | Patient Satisfaction With Care: Find Value in a Physician | Probably not | 1 Participants |
| Usual Care | Patient Satisfaction With Care: Find Value in a Physician | Probably so | 7 Participants |
| Usual Care | Patient Satisfaction With Care: Find Value in a Physician | Definitely so | 34 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Find Value in a Physician | Definitely so | 30 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Find Value in a Physician | Definitely not | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Find Value in a Physician | Probably so | 2 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Find Value in a Physician | Probably not | 1 Participants |
Secondary
Patient Satisfaction With Care: Hospitalization
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Hospitalization | Yes | 43 Participants |
| Usual Care | Patient Satisfaction With Care: Hospitalization | No | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Hospitalization | Yes | 34 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Hospitalization | No | 0 Participants |
Secondary
Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 42 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | A little of the time | 4 Participants |
| Usual Care | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | Most of the time | 6 Participants |
| Usual Care | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | Some of the time | 3 Participants |
| Usual Care | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | All of the time | 12 Participants |
| Usual Care | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | None of the time | 17 Participants |
| New Critical Pathway | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | All of the time | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | None of the time | 26 Participants |
| New Critical Pathway | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | A little of the time | 5 Participants |
| New Critical Pathway | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | Some of the time | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: IV Therapy Hindering Normal Activities of Daily Living | Most of the time | 1 Participants |
Secondary
Patient Satisfaction With Care: Overall Health
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Overall Health | Very good | 16 Participants |
| Usual Care | Patient Satisfaction With Care: Overall Health | Fair | 10 Participants |
| Usual Care | Patient Satisfaction With Care: Overall Health | Good | 9 Participants |
| Usual Care | Patient Satisfaction With Care: Overall Health | Poor | 6 Participants |
| Usual Care | Patient Satisfaction With Care: Overall Health | Excellent | 2 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Overall Health | Poor | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Overall Health | Excellent | 8 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Overall Health | Very good | 10 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Overall Health | Good | 7 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Overall Health | Fair | 8 Participants |
Secondary
Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections | Yes | 43 Participants |
| Usual Care | Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections | No | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections | Yes | 33 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Received IV Antibiotic Therapy for Skin Infections | No | 1 Participants |
Secondary
Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 34 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 1 | 28 Participants |
| Usual Care | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 2 | 6 Participants |
| Usual Care | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 3 | 9 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 1 | 33 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 2 | 0 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Regimen Preferred if Treated Again for a Similar Skin Infection With IV | Regimen 3 | 1 Participants |
Secondary
Patient Satisfaction With Care: Satisfaction With Hospital Stay
Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.
Time frame: 14 Days
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Satisfaction With Hospital Stay | 7.4 scores on a scale | Standard Deviation 2.35 |
| New Critical Pathway | Patient Satisfaction With Care: Satisfaction With Hospital Stay | 7.4 scores on a scale | Standard Deviation 2.72 |
Secondary
Patient Satisfaction With Care: Satisfaction With Receiving IV Antibiotic Therapy
Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Satisfaction With Receiving IV Antibiotic Therapy | 7.1 scores on a scale | Standard Deviation 2.83 |
| New Critical Pathway | Patient Satisfaction With Care: Satisfaction With Receiving IV Antibiotic Therapy | 8.1 scores on a scale | Standard Deviation 2.26 |
Secondary
Patient Satisfaction With Care: Satisfaction With the Average Time to Administer Each IV
Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Satisfaction With the Average Time to Administer Each IV | 7.5 scores on a scale | Standard Deviation 2.58 |
| New Critical Pathway | Patient Satisfaction With Care: Satisfaction With the Average Time to Administer Each IV | 8.9 scores on a scale | Standard Deviation 1.9 |
Secondary
Patient Satisfaction With Care: Satisfied With the Number of IV Infusions Received Per Day
Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 43 \& 33 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Satisfied With the Number of IV Infusions Received Per Day | 7.3 scores on a scale | Standard Deviation 2.63 |
| New Critical Pathway | Patient Satisfaction With Care: Satisfied With the Number of IV Infusions Received Per Day | 8.7 scores on a scale | Standard Deviation 1.89 |
Secondary
Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV
Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).
Time frame: 14 Days
Population: FAS Population. 43 \& 34 patients provided any survey data in the usual care group \& new critical pathway group; 40 \& 32 patients completed all survey questions in the usual care group \& new critical pathway group; 41 \& 34 patients answered this survey question in the usual care group \& new critical pathway group, respectively.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 30 minutes or less | 23 Participants |
| Usual Care | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 1 hour | 10 Participants |
| Usual Care | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 1.5 to 2 hours | 5 Participants |
| Usual Care | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 3 hours or longer | 3 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 3 hours or longer | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 30 minutes or less | 22 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 1.5 to 2 hours | 1 Participants |
| New Critical Pathway | Patient Satisfaction With Care: Time Willing to Spend Receiving Each IV | About 1 hour | 10 Participants |
Secondary
Patient Satisfaction With Care: Wait in Emergency Room
Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.
Time frame: 14 Days
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Usual Care | Patient Satisfaction With Care: Wait in Emergency Room | 5.1 scores on a scale | Standard Deviation 3.34 |
| New Critical Pathway | Patient Satisfaction With Care: Wait in Emergency Room | 6.9 scores on a scale | Standard Deviation 3.12 |
Secondary
Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire
Time frame: Day 10-14
Population: FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively.14 and 9 patients completed all survey questions in the usual care group and new critical pathway group, respectively. 17 and 20 patients were employed.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Usual Care | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Absenteeism | 49.9 Percentage | Standard Deviation 38.49 |
| Usual Care | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Impairment while working | 47.9 Percentage | Standard Deviation 40.03 |
| Usual Care | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Overall work impairment | 59.3 Percentage | Standard Deviation 39.16 |
| Usual Care | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Activity impairment | 60.2 Percentage | Standard Deviation 38.85 |
| New Critical Pathway | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Activity impairment | 18.5 Percentage | Standard Deviation 26.23 |
| New Critical Pathway | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Absenteeism | 36.7 Percentage | Standard Deviation 46.09 |
| New Critical Pathway | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Overall work impairment | 18.0 Percentage | Standard Deviation 23.39 |
| New Critical Pathway | Patient Work and Productivity Loss as Assessed Through the Work Productivity and Activity Impairment Questionnaire | Impairment while working | 8.9 Percentage | Standard Deviation 9.28 |
Secondary
Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy
Time frame: 44 Days
Population: Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Usual Care | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | Central Line | 0 Participants |
| Usual Care | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | PICC Line | 1 Participants |
| Usual Care | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | Peripheral IV | 27 Participants |
| Usual Care | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | No Line | 20 Participants |
| New Critical Pathway | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | No Line | 0 Participants |
| New Critical Pathway | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | Central Line | 0 Participants |
| New Critical Pathway | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | Peripheral IV | 42 Participants |
| New Critical Pathway | Use of a Peripherally-Inserted Central Catheter (PICC) Line or Central Line to Administer Antibiotic Therapy | PICC Line | 0 Participants |